{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T09:01:48Z","timestamp":1726131708297},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1002\/jcph.685","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T10:16:35Z","timestamp":1449224195000},"page":"862-868","source":"Crossref","is-referenced-by-count":3,"title":["Acetylsalicylic Acid Daily vs Acetylsalicylic Acid Every 3 Days in Healthy Volunteers: Effect on Platelet Aggregation, Gastric Mucosa, and Prostaglandin E<sub>2<\/sub>Synthesis"],"prefix":"10.1002","volume":"56","author":[{"given":"Plinio Minghin Freitas","family":"Ferreira","sequence":"first","affiliation":[{"name":"Department of Pharmacology; Biomedical Sciences Institute; University of Sao Paulo; Sao Paulo SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago","family":"Gagliano-Juc\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Biophysics Carlos Chagas Filho; Federal University of Rio de Janeiro; Rio de Janeiro RJ Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Zaminelli","sequence":"additional","affiliation":[{"name":"Department of Pharmacology; Faculty of Medical Sciences; State University of Campinas (Unicamp); Campinas SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinalva Ferreira","family":"Sampaio","sequence":"additional","affiliation":[{"name":"Galeno Research Unit; Campinas SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory Willian","family":"Blackler","sequence":"additional","affiliation":[{"name":"Farncombe Family Digestive Health Research Institute; McMaster University; Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam da Silva","family":"Trevisan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Faculty of Medical Sciences; State University of Campinas (Unicamp); Campinas SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Frederico","family":"Novaes Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Faculty of Medical Sciences; State University of Campinas (Unicamp); Campinas SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"De Nucci","sequence":"additional","affiliation":[{"name":"Department of Pharmacology; Biomedical Sciences Institute; University of Sao Paulo; Sao Paulo SP Brazil"},{"name":"Department of Pharmacology; Faculty of Medical Sciences; State University of Campinas (Unicamp); Campinas SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"10.1002\/jcph.685-BIB0001|jcph685-cit-0001","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol."},{"key":"10.1002\/jcph.685-BIB0002|jcph685-cit-0002","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1002\/jcph.685-BIB0003|jcph685-cit-0003","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat Struct Biol."},{"issue":"Suppl 1","key":"10.1002\/jcph.685-BIB0004|jcph685-cit-0004","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1111\/j.1365-2125.1983.tb02104.x","article-title":"Human blood platelet behaviour after inhibition of thromboxane synthetase","volume":"15","author":"Heptinstall","year":"1983","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.685-BIB0005|jcph685-cit-0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","article-title":"Antiplatelet therapies for the treatment of cardiovascular disease","volume":"9","author":"Michelson","year":"2010","journal-title":"Nat Rev Drug Discovery."},{"key":"10.1002\/jcph.685-BIB0006|jcph685-cit-0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists C","year":"2002","journal-title":"BMJ."},{"key":"10.1002\/jcph.685-BIB0007|jcph685-cit-0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2005.11.013","article-title":"Aspirin to prevent heart attack and stroke: what's the right dose?","volume":"119","author":"Dalen","year":"2006","journal-title":"Am J Med."},{"key":"10.1002\/jcph.685-BIB0008|jcph685-cit-0008","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/1756-0500-6-455","article-title":"Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers","volume":"6","author":"Kawamura","year":"2013","journal-title":"BMC Res Notes."},{"key":"10.1002\/jcph.685-BIB0009|jcph685-cit-0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/284271a0","article-title":"Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa","volume":"284","author":"Whittle","year":"1980","journal-title":"Nature."},{"key":"10.1002\/jcph.685-BIB0010|jcph685-cit-0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-120-3-199402010-00002","article-title":"Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury","volume":"120","author":"Lee","year":"1994","journal-title":"Ann Intern Med."},{"key":"10.1002\/jcph.685-BIB0011|jcph685-cit-0011","first-page":"751","article-title":"Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor","volume":"51","author":"Brzozowski","year":"2000","journal-title":"J Physiol Pharmacol."},{"key":"10.1002\/jcph.685-BIB0012|jcph685-cit-0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","article-title":"Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice","volume":"112","author":"Mizuno","year":"1997","journal-title":"Gastroenterology."},{"key":"10.1002\/jcph.685-BIB0013|jcph685-cit-0013","doi-asserted-by":"crossref","first-page":"G788","DOI":"10.1152\/ajpgi.00131.2007","article-title":"Cyclooxygenase-2\/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors","volume":"293","author":"Hatazawa","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1002\/jcph.685-BIB0014|jcph685-cit-0014","doi-asserted-by":"crossref","first-page":"G1113","DOI":"10.1152\/ajpgi.2000.279.5.G1113","article-title":"Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans","volume":"279","author":"Feldman","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1002\/jcph.685-BIB0015|jcph685-cit-0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1152\/physrev.1982.62.1.185","article-title":"Human platelet size, shape, and related functions in health and disease","volume":"62","author":"Frojmovic","year":"1982","journal-title":"Physiol Rev."},{"key":"10.1002\/jcph.685-BIB0016|jcph685-cit-0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107602960100700111","article-title":"A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women","volume":"7","author":"Feldman","year":"2001","journal-title":"Clin Appl Thromb Hemostas."},{"key":"10.1002\/jcph.685-BIB0017|jcph685-cit-0017","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9343(86)90289-5","article-title":"Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood","volume":"81","author":"Stampfer","year":"1986","journal-title":"Am J Med."},{"key":"10.1002\/jcph.685-BIB0018|jcph685-cit-0018","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0049-3848(87)90224-6","article-title":"Effects of low doses of aspirin, 10\u00a0mg and 30\u00a0mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects","volume":"45","author":"Kallmann","year":"1987","journal-title":"Thromb Res."},{"key":"10.1002\/jcph.685-BIB0019|jcph685-cit-0019","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest."},{"key":"10.1002\/jcph.685-BIB0020|jcph685-cit-0020","article-title":"Pharmacokinetic and pharmacodynamic evaluation of administration of losartan with aspirin in healthy volunteers","author":"Mendes","year":"2013.","journal-title":"Proc Br Pharmacol Soc."},{"key":"10.1002\/jcph.685-BIB0021|jcph685-cit-0021","article-title":"ASA daily vs ASA every 3 days in healthy volunteers: effect on platelet aggregation and gastric mucosa PGE2 synthesis","author":"Ferreira","year":"2014.","journal-title":"Proc Br Pharmacol Soc."},{"key":"10.1002\/jcph.685-BIB0022|jcph685-cit-0022","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5414\/CPP44142","article-title":"Comparative bioavailability of two losartan formulations in healthy human volunteers after a single dose administration","volume":"44","author":"Oliveira","year":"2006","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1002\/jcph.685-BIB0023|jcph685-cit-0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.448","article-title":"Comparative pharmacokinetics of two tablet formulations of losartan: bioequivalence assessment","volume":"26","author":"Tamimi","year":"2005","journal-title":"Biopharm Drug Dispos."},{"key":"10.1002\/jcph.685-BIB0024|jcph685-cit-0024","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1345\/aph.1R273","article-title":"A review of the use of angiotensin receptor blockers for the prevention of cardiovascular events in patients with essential hypertension without compelling indications","volume":"47","author":"Zaiken","year":"2013","journal-title":"Ann Pharmacother."},{"key":"10.1002\/jcph.685-BIB0025|jcph685-cit-0025","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1345\/aph.19296","article-title":"Combined aspirin\/ACE inhibitor treatment for CHF","volume":"35","author":"Olson","year":"2001","journal-title":"Ann Pharmacother."},{"key":"10.1002\/jcph.685-BIB0026|jcph685-cit-0026","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens."},{"key":"10.1002\/jcph.685-BIB0027|jcph685-cit-0027","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC\/ISTH","volume":"11","author":"Cattaneo","year":"2013","journal-title":"J Thromb Haemostas."},{"key":"10.1002\/jcph.685-BIB0028|jcph685-cit-0028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0016-5085(99)70545-7","article-title":"Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans","volume":"117","author":"Cryer","year":"1999","journal-title":"Gastroenterology."},{"key":"10.1002\/jcph.685-BIB0029|jcph685-cit-0029","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet."},{"key":"10.1002\/jcph.685-BIB0030|jcph685-cit-0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75\u00a0mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","author":"The SALT Collaborative Group.","year":"1991","journal-title":"Lancet."},{"key":"10.1002\/jcph.685-BIB0031|jcph685-cit-0031","first-page":"817","volume-title":"Physiology of the Gastrointestinal Tract","author":"Ito","year":"1987"},{"key":"10.1002\/jcph.685-BIB0032|jcph685-cit-0032","first-page":"144","article-title":"Pharmacokinetic evaluation of administration of losartan with aspirin in healthy volunteers","volume":"7","author":"Mendes","year":"2015","journal-title":"J Bioequiv Availability."},{"key":"10.1002\/jcph.685-BIB0033|jcph685-cit-0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-015-0244-x","article-title":"High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study","volume":"14","author":"Shlomai","year":"2015","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1002\/jcph.685-BIB0034|jcph685-cit-0034","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2011.04304.x","article-title":"Increased platelet turnover in patients with previous definite stent thrombosis","volume":"9","author":"Grove","year":"2011","journal-title":"J Thromb Haemostas"},{"key":"10.1002\/jcph.685-BIB0035|jcph685-cit-0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinthera.2011.02.003","article-title":"Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review","volume":"33","author":"Zedler","year":"2011","journal-title":"Clin Ther."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.685","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.685\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:03:19Z","timestamp":1657803799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.685"}},"subtitle":["Acetylsalicylic Acid Daily vs Acetylsalicylic"],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.685","archive":["Portico"],"relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}